Locus coeruleus pathology in progressive supranuclear palsy is associated with disease severity

被引：0
|
作者：
Kaalund, S. S. [1 ,2 ]
Passamonti, L. [1 ,2 ]
Allinson, K. S. J. [3 ,4 ]
Murley, A. G. [1 ,2 ]
Robbins, T. W. [5 ,6 ]
Spillantini, M. G. [1 ,2 ]
Rowe, J. B. [1 ,2 ]
机构：
[1] Univ Cambridge, Cambridge Ctr Frontotemporal Dementia, Cambridge, England
[2] Univ Cambridge, Dept Clin Neurosci, Cambridge, England
[3] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[4] Cambridge Brain Bank, Cambridge, England
[5] Univ Cambridge, Dept Psychol, Cambridge, England
[6] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England
来源：
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY | 2020年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O21
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [11] The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Caregivers
    Xie, T.
    Ye, X.
    De Courcy, J.
    Golden, K.
    Bao, Y.
    Zamudio, J.
    Chiodo, L.
    Morgan, J.
    MOVEMENT DISORDERS, 2019, 34 : S260 - S261
  • [12] Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology
    Heckman, Michael G.
    Brennan, Rebecca R.
    Labbe, Catherine
    Soto, Alexandra I.
    Koga, Shunsuke
    DeTure, Michael A.
    Murray, Melissa E.
    Petersen, Ronald C.
    Boeve, Bradley F.
    van Gerpen, Jay A.
    Uitti, Ryan J.
    Wszolek, Zbigniew K.
    Rademakers, Rosa
    Dickson, Dennis W.
    Ross, Owen A.
    JAMA NEUROLOGY, 2019, 76 (06) : 710 - 717
  • [13] The severity and distribution of tau pathology distinguish corticobasal degeneration and progressive supranuclear palsy
    Koga, S.
    Ghayal, N.
    Roemer, S.
    Dickson, D.
    MOVEMENT DISORDERS, 2020, 35 : S505 - S505
  • [14] Genetics of the tau locus in progressive supranuclear palsy
    de Silva, R
    Lees, A
    MOVEMENT DISORDERS, 2002, 17 (06) : 1405 - 1405
  • [15] The spinal cord pathology of progressive supranuclear palsy
    Vitaliani, R
    Scaravilli, T
    Pramstaller, PP
    Tavolato, B
    Giometto, B
    Scaravilli, F
    NEUROLOGY, 2001, 56 (08) : A443 - A443
  • [16] NEUROFIBRILLARY PATHOLOGY IN PROGRESSIVE SUPRANUCLEAR PALSY (PSP)
    CERVOSNAVARRO, J
    SCHUMACHER, K
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1994, (42): : 153 - 164
  • [17] Severity of tau deposition in progressive supranuclear palsy is associated with clinical phenotype
    Williams, D. R.
    Holton, J. L.
    Lees, A. J.
    Revesz, T.
    MOVEMENT DISORDERS, 2007, 22 : S260 - S260
  • [18] Progressive supranuclear palsy with dementia: Cortical pathology
    Bigio, EH
    Brown, DF
    White, CL
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (04): : 359 - 364
  • [19] The pathology of the spinal cord in progressive supranuclear palsy
    Vitaliani, R
    Scaravilli, T
    Egarter-Vigl, E
    Giometto, B
    Klein, C
    Scaravilli, F
    An, SF
    Pramstaller, PP
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (03): : 268 - 274
  • [20] Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy
    Chen, Ming-Jia
    Lu, Jia-Ying
    Li, Xin-Yi
    Jiao, Fang-Yang
    Zuo, Chuan-Tao
    Wang, Jian
    Liu, Feng-Tao
    Yang, Yu-Jie
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
12345